Chronic otitis media with effusion

K A Daly1, L L Hunter, G S Giebink

  • 1University of Minnesota, Otitis Media Research Center, Department of Otolaryngology, University of Minnesota School of Medicine, Minneapolis, USA.

Pediatrics in Review
|March 12, 1999
PubMed

Insights

Chronic otitis media with effusion (OME) affects many children, causing temporary hearing loss and potential developmental delays. Early diagnosis and intervention are crucial for managing this common middle ear condition.

Area of Science:

  • Pediatrics
  • Otolaryngology
  • Infectious Diseases

Background:

  • Chronic otitis media with effusion (OME) is a prevalent condition in children, stemming from middle ear inflammation.
  • It affects 5% to 30% of children, with middle ear effusion (MEE) lasting 16–20 weeks in the first two years of life.
  • Risk factors include environmental influences and individual child characteristics, with common bacterial pathogens identified in culture-positive cases.

Purpose of the Study:

  • To review the diagnosis, treatment, and sequelae of chronic otitis media with effusion in children.
  • To highlight the impact of OME on child development and hearing.
  • To discuss recommended management strategies for persistent MEE.

Main Methods:

  • Diagnosis relies on pneumatic otoscopy and tympanometry.
  • Evaluation of treatment efficacy, including antibiotic use.
  • Assessment of long-term consequences and developmental impacts.

Main Results:

  • Antibiotic treatment shows minimal long-term benefit for MEE resolution.
  • Approximately 70% of children with chronic OME experience mild-to-moderate hearing loss.
  • Sequelae include language deficits, attention issues, and various tympanic membrane pathologies.

Conclusions:

  • Children with bilateral MEE for 3 months require hearing evaluation.
  • Myringotomy and tympanostomy tube insertion are recommended for hearing impairment after 4 months of effusion.
  • Prompt management of OME is essential to prevent lasting developmental and auditory complications.

Related Concept Videos

Chronic Obstructive Pulmonary Disease01:24

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Pleural Effusion I: Introduction01:25

Pleural Effusion I: Introduction

Pleural effusion is an abnormal fluid accumulation in the pleural cavity, a narrow space between the lungs and the chest wall. It is not a disease per se but rather a symptom or indication of an underlying disease. In normal circumstances, this space contains a small amount of fluid (5 to 15 mL), a lubricant facilitating the non-frictional movement of the pleural surfaces.
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's criteria,...
Pleural Effusion II: Symptoms and Management01:28

Pleural Effusion II: Symptoms and Management

Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations01:19

Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations

Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet cell...